Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-H0731 in Combination With Entecavir ± Peginterferon alfa-2a for Chronic Hepatitis B
CTR20210059Phase 2Terminated
- Sponsor
- Assembly Biosciences, Inc.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vebicorvir in Chronic Hepatitis B (CHB), sponsored by Assembly Biosciences, Inc.. Started Jan 2021; status: terminated.
02
Drugs
vebicorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20210059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210059.